Home » Topics » Regulatory » Patents

Patents
RSS

SmithKline Beecham describes novel compounds for depression and other CNS disorders

Jan. 18, 1999

Dopamine D3 antagonists for psychoses and other D3 ligands designed at SmithKline Beecham

Jan. 15, 1999

Urea derivatives acting at multiple 5-HT receptor subtypes emerge from SB R&D

Jan. 15, 1999

Agouron's new MMP inhibitors described in patent literature

Jan. 15, 1999

Indole-based antimigraine agents in development at Allelix

Jan. 15, 1999

Cardioprotective benzoylguanidines with improved properties claimed by Hoechst

Jan. 15, 1999

Novel compounds developed at Roche for lipid disorders and fungal infections

Jan. 15, 1999

Vanadium complexes claimed by Angiotech for wide range of proliferative disorders

Jan. 14, 1999

Human mindin polypeptides and polynucleotides for angiogenic diseases

Jan. 14, 1999

Peripherally selective kappa-opioid agonists in early development at Warner-Lambert

Jan. 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...